August, 2025
August 2025
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
Tarlatamab and Lurbinectedin-Atezolizumab Combination Therapy Trials Meet Survival Endpoints: Alfredo Addeo in ESMO Daily Reporter
Jun 14, 2025, 13:43

Tarlatamab and Lurbinectedin-Atezolizumab Combination Therapy Trials Meet Survival Endpoints: Alfredo Addeo in ESMO Daily Reporter

The European Society for Medical Oncology (ESMO) shared a post on X:

“Two studies investigating efficacy of bispecific T-cell engager tarlatamab and lurbinectedin – atezolizumab combination met their primary endpoints of survival.
Read the opinion by Alfredo Addeo in the ESMO Daily Reporter․

More posts featuring ESMO Daily Reporter on OncoDaily.